CineVerge maps out 11-series vertical slate and five-year growth plan

CineVerge has announced 11 optioned, rights-controlled vertical series and a five-year plan to produce 30 distinct titles and 90 total seasons. The Palm Coast, Florida studio is building a human-led, AI-assisted library for licensing to vertical microseries platforms.

Why it matters: - CineVerge is trying to build a repeatable supply of scripted vertical content for a fast-growing microseries market. - The company’s five-year target of 30 series and 90 seasons signals an ambition to scale beyond a single proof-of-concept title. - The model is designed for licensing, which positions CineVerge as a business-to-business studio rather than a direct-to-consumer streamer.

What happened: - CineVerge announced a current production and development slate of 11 optioned, rights-controlled vertical series. - The announcement came as the company outlined a five-year production plan built around growing its scripted entertainment library. - CineVerge said the plan includes 30 distinct vertical series across its first five years. - CineVerge said it expects to produce 90 total seasons across new and returning titles. - The production ramp is set to grow from six seasons in Year 1 to 30 seasons in Year 5. - The company said the slate will expand as successful series return and new projects are added. - CineVerge is based in Palm Coast, Florida, and is organized as a Delaware C corporation.

The details: - The company’s current five-year development pipeline includes 18 projects. - That pipeline consists of 11 optioned, rights-controlled titles and seven additional prospective titles under evaluation or development. - Twelve of the planned 30 new-series selections remain open for future creator, rights, and market evaluation. - CineVerge described its production model as human-led and AI-assisted. - AI tools support approved development, picture, and audio tasks. - Human creative professionals evaluate, revise, direct, approve, and lock the work. - CineVerge’s business model is B2B, with annual completed slates intended for licensing to vertical microseries platforms. - The company said the five-year plan is intended to support 90 season-production cycles across thriller, horror, science fiction, fantasy, mystery, crime, and comedy. - Christopher C. Odom, MFA, PhD, is founder, president and CEO of CineVerge. - Odom said the company is building value through rights-controlled stories, a repeatable production process, disciplined records, production and sales data, and buyer relationships. - CineVerge said the announcement follows a November 3, 2026 Founder Stories profile by Every.io covering the company’s strategy, Odom’s background, The Test, and the studio’s approach to vertical entertainment.

Between the lines: - CineVerge is emphasizing control of rights and process, not just AI use, as its competitive edge. - The open slots in the slate suggest the company is still testing creators and concepts while it builds out its production engine. - The mix of genres points to a strategy of broadening the company’s addressable audience across the vertical-series category. - Positioning The Test as a 100-episode proof-of-concept suggests CineVerge is using one flagship series to validate both production workflow and buyer demand.

What's next: - CineVerge will continue evaluating creators, concepts, rights readiness, and market opportunities as it fills the remaining open slots. - The company is expected to move its Year 1 slate forward from six seasons toward the larger multi-year production schedule. - The current titles in production, pre-production, and optioned development will be part of the company’s next slate-building phase. - CineVerge will likely use completed annual packages to pursue licensing deals with vertical microseries platforms.

The bottom line: - CineVerge is betting that a rights-controlled, human-led, AI-assisted production system can turn vertical microseries into a scalable studio business.